“A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform”

//“A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform”

“A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform”

Register now for “A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform,” a complimentary, educational webinar sponsored by Gyros, featuring Ann-Charlott Steffen of AstraZeneca and Mark Cameron and Andreea Halford of MPI Research, on Wednesday, March 21, 2012, from 11 am to 12:30 pm ET.

Learn about

  • The cutting-edge developments associated with a single mouse approach in PK/PD bioanalysis
  • An automated nanoliter-scale immunoassay platform
  • Performance and productivity of ligand-binding assays

Drug metabolism and pharmacokinetic (DMPK) studies in support of drug candidate selection or regulatory submission are often challenging, with limited volumes available for analysis. Join Mark Cameron and Andreea Halford of MPI Research, along with Ann-Charlott Steffen of AstraZeneca, to explore the new developments of a single mouse approach in PK/PD bioanalysis, using an automated nanoliter-scale immunoassay platform, and its impact on redefining performance and productivity of ligand-binding assays in the early development of biotherapeutics. Click here to register for this webinar.

By |2017-07-04T10:29:25+00:00March 7th, 2012|News|Comments Off on “A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform”

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.